Aberrant KIF2C expression has been observed in cancers and overexpression of KIF2C is associated with cancer progression, invasion, metastasis, and poor prognosis, particularly in breast 67, 68, gastric 69, and colorectal cancer 70, 71. This evidence concerns the gene KIF2C and colorectal cancer.